Drugmakers Bristol Myers Squibb (BMS) and Vertex both issued changes to their contract pharmacy policies this month on 340B ESP’s website. 

BMS Allows Additional Contract Pharmacy Designation for Cancer Drug; Vertex Adds Cystic Fibrosis Drug to Restrictions

Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions  that apply to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live